Dr. Sina Tebi, M.D
NPI: 1437380789
Total Payments
$226,858
2024 Payments
$91,161
Companies
55
Transactions
1,714
Medicare Patients
6,355
Medicare Billing
$1.3M
Payment Breakdown by Category
Research$105,110 (46.3%)
Other$70,634 (31.1%)
Food & Beverage$34,792 (15.3%)
Consulting$9,880 (4.4%)
Travel$6,039 (2.7%)
Education$342.96 (0.2%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $105,110 | 15 | 46.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,034 | 56 | 30.4% |
| Food and Beverage | $34,792 | 1,586 | 15.3% |
| Consulting Fee | $9,880 | 6 | 4.4% |
| Travel and Lodging | $6,039 | 30 | 2.7% |
| Honoraria | $1,600 | 1 | 0.7% |
| Education | $342.96 | 19 | 0.2% |
| Gift | $59.40 | 1 | 0.0% |
Payments by Type
General
$121,748
1,699 transactions
Research
$105,110
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $106,776 | 16 | $0 (2024) |
| Lilly USA, LLC | $46,816 | 171 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,428 | 148 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $13,976 | 113 | $0 (2024) |
| Corcept Therapeutics | $10,112 | 66 | $0 (2024) |
| Mannkind Corporation | $8,953 | 156 | $0 (2024) |
| Dexcom, Inc. | $5,769 | 133 | $0 (2024) |
| Novo Nordisk Inc | $4,421 | 311 | $0 (2024) |
| Abbott Laboratories | $2,034 | 77 | $0 (2024) |
| Amgen Inc. | $1,378 | 68 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91,161 | 253 | Eli Lilly and Company ($79,809) |
| 2023 | $34,947 | 309 | Lilly USA, LLC ($16,366) |
| 2022 | $45,326 | 362 | Lilly USA, LLC ($23,641) |
| 2021 | $22,572 | 248 | SANOFI-AVENTIS U.S. LLC ($8,904) |
| 2020 | $8,067 | 155 | Corcept Therapeutics ($5,819) |
| 2019 | $5,891 | 130 | SANOFI-AVENTIS U.S. LLC ($3,222) |
| 2018 | $10,091 | 135 | Eli Lilly and Company ($5,315) |
| 2017 | $8,804 | 122 | Eli Lilly and Company ($6,152) |
All Payment Transactions
1,714 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Endocrinology | ||||||
| 12/29/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Automated insulin delivery system | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes Care | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes Care | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes Care | ||||||
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $44.96 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 12/18/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $20.26 | General |
| 12/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $157.12 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: LIVER DISEASE | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $11.95 | General |
| 11/26/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: DIABETES MEDICINE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | Eli Lilly and Company | $79,809 | 1 |
| A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE | Eli Lilly and Company | $15,114 | 2 |
| A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO INSULIN LISPRO, BOTH IN COMBINATION WITH INSULIN GLARGINE OR INSULIN DEGLUDEC IN ADULTS WITH TYPE 2 DIABETES PRONTO-T2D | Eli Lilly and Company | $4,934 | 1 |
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $4,136 | 2 |
| M16-100 | AbbVie, Inc. | $731.25 | 8 |
| A DONANEMAB (LY3002813) PREVENTION STUDY IN PARTICIPANTS WITH ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 3) | Eli Lilly and Company | $386.35 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,513 | 3,605 | $782,440 | $331,181 |
| 2022 | 18 | 1,726 | 3,934 | $849,625 | $365,931 |
| 2021 | 18 | 1,595 | 3,494 | $775,830 | $351,162 |
| 2020 | 16 | 1,521 | 2,941 | $611,845 | $262,047 |
Total Patients
6,355
Total Services
13,974
Medicare Billing
$1.3M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 569 | 1,786 | $410,780 | $173,397 | 42.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 445 | $66,750 | $29,499 | 44.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 246 | $54,120 | $24,524 | 45.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 176 | 215 | $43,000 | $21,911 | 51.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 117 | 131 | $56,330 | $19,013 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 81 | $24,300 | $12,262 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 68 | 68 | $30,600 | $12,214 | 39.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 68 | $34,000 | $12,020 | 35.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 97 | 244 | $23,180 | $7,027 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $13,650 | $5,326 | 39.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 25 | 28 | $5,600 | $3,812 | 68.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 68 | $6,120 | $3,350 | 54.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 24 | 27 | $5,400 | $3,257 | 60.3% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 17 | 24 | $2,400 | $1,234 | 51.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 96 | $2,880 | $1,172 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $3,150 | $1,139 | 36.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 18 | $180.00 | $23.77 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 548 | 1,671 | $384,330 | $171,172 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 138 | 671 | $100,650 | $40,500 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 181 | 353 | $77,660 | $30,616 | 39.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 154 | 171 | $73,530 | $28,485 | 38.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 165 | 207 | $41,400 | $21,540 | 52.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 91 | 91 | $40,950 | $16,981 | 41.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 84 | $42,000 | $15,411 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 68 | $20,400 | $10,336 | 50.7% |
About Dr. Sina Tebi, M.D
Dr. Sina Tebi, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437380789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sina Tebi, M.D has received a total of $226,858 in payments from pharmaceutical and medical device companies, with $91,161 received in 2024. These payments were reported across 1,714 transactions from 55 companies. The most common payment nature is "" ($105,110).
As a Medicare-enrolled provider, Tebi has provided services to 6,355 Medicare beneficiaries, totaling 13,974 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Diabetes & Metabolism
- Location Los Angeles, CA
- Active Since 08/04/2009
- Last Updated 04/22/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437380789
Products in Payments
- MOUNJARO (Drug) $31,341
- JARDIANCE (Drug) $22,273
- Korlym (Drug) $10,112
- AFREZZA (Drug) $8,953
- TRULICITY (Drug) $6,010
- TOUJEO (Biological) $5,824
- SOLIQUA 100/33 (Biological) $3,642
- DISEASE STATE (Drug) $2,750
- Dexcom CGM (Device) $2,460
- Dexcom G6 Transmitter (Medical Supply) $2,340
- Ozempic (Drug) $2,336
- LYUMJEV (Drug) $1,300
- FARXIGA (Drug) $1,040
- FREESTYLE LIBRE 3 (Device) $1,022
- Omnipod (Device) $997.13
- Androgel (Drug) $865.75
- Kerendia (Drug) $863.63
- Rybelsus (Drug) $756.73
- TRADJENTA (Drug) $568.69
- EVENITY (Biological) $552.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Los Angeles
Dr. Sadeea Abbasi, M.d., Ph.d, M.D., PH.D
Student in an Organized Health Care Education/Training Program — Payments: $394,199
Student in an Organized Health Care Education/Training Program $394,199
Dr. Edward Nomoto, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $376,152
Student in an Organized Health Care Education/Training Program $376,152
Dr. Matthew Herrmann, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $248,245
Student in an Organized Health Care Education/Training Program $248,245
Chanook Ahn, Dmd, DMD
Student in an Organized Health Care Education/Training Program — Payments: $233,441
Student in an Organized Health Care Education/Training Program $233,441
Arjan Hura, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $188,267
Student in an Organized Health Care Education/Training Program $188,267
Dr. Rachel Reyes-Bergano, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $161,741
Student in an Organized Health Care Education/Training Program $161,741